Update on HSA's Consideration of COVID-19 Vaccines for Children and Progress of Obtaining Approval

64 Assoc Prof Jamus Jerome Lim asked the Minister for Health regarding COVID-19 vaccination of children below 12 years of age, whether the Ministry can provide an update on (i) the vaccines that are currently under study or consideration by HSA and (ii) the progress of obtaining approval for use of these vaccines.

Mr Ong Ye Kung: I thank the Member for his question. I have addressed it in my reply to Question No. 72 for oral answer on the Order Paper for 1 November 2021. [Please refer to "Assessment Criteria for Sinovac and Sinopharm COVID-19 Vaccines for Inclusion in National Vaccination Programme", Official Report, 1 November 2021, Vol 95, Issue 41, Written Answers to Questions for Oral Answer Not Answered by End of Question Time section.]